Motivational Interviewing for HCV Elimination

Not Applicable

Terminated

• Conditions: Hepatitis C
• Interventions: Behavioral: Motivational Interviewing Training

• Registration Number: NCT03804814
• Lead Sponsor: Nova Scotia Health Authority

Brief Summary

This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-12-06
• Study First Submitted QC: 2019-01-11
• Study First Posted: 2019-01-15
• Study Start: 2019-05-21
• Primary Completion: 2021-10-04
• Study Completion: 2021-10-04
• Status Verified: 2023-02
• Last Update Submitted: 2023-02-07
• Last Update Posted: 2023-02-10

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

• Willingness to participate and provide informed consent
• Positive HCV RNA Result
• ≥18 years of age

Patient

Exclusion Criteria

• Unwilling or unable to provide consent

Health Care Provider Inclusion Criteria:

• Willingness to participate and provide informed consent
• Has a hepatitis C care experience

Health Care Provider Exclusion Criteria:

• Unwilling or unable to provide consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Motivational Interviewing Training	Motivational Interviewing Training	Health care providers will be trained in motivational interviewing for use in Hepatitis C patient encounters.

Primary Outcome Measures

Name	Time	Method
HCV Treatment Completion	Through study completion, an average of 2 years	To measure the number of patients who complete HCV therapy

Secondary Outcome Measures

Name	Time	Method
Time to complete prescribed HCV treatment course	Through study completion, an average of 2 years
Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire	Through study completion, an average of 2 years
Number of unique Hepatitis C related and unrelated health system visits	Through study completion, an average of 2 years
Time from care engagement to treatment initiation	Through study completion, an average of 2 years
Number of scheduled and attended medical care appointments	Through study completion, an average of 2 years
Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire	Through study completion, an average of 2 years
Percentage of eligible individuals that initiate HCV therapy	Through study completion, an average of 2 years

Trial Locations

Locations (1)

Nova Scotia Health Authority; 🇨🇦 Halifax, Nova Scotia, Canada